Global Partners

USAID supports, enhances, and provides leadership to many global partnerships in the health sector. These partnerships complement USAID's existing programs and, by leveraging new resources, expertise, and technologies, offer greater opportunities to achieve development objectives.

• Global Alliance for TB Drug Development
  USAID's agreement with the Global Alliance for TB Drug Development supports the Alliance's program to identify promising lead compounds and drug candidates, carry out clinical trials of drug candidates, and to move candidate compounds along the drug development pipeline to registration.
  
  
• Global TB Drug Facility (GDF)
  USAID provides support for grants for TB drugs, technical assistance and monitoring of GDF grant recipients, and pre-qualification of TB drug suppliers.
  
  
• Stop TB Partnership
  USAID support is provided to the Stop TB Partnership for country level advocacy, communications and social mobilization activities, the development of national STOP TB partnerships, and monitoring of global financial support for TB control.
  
  
• World Health Organization (WHO)
  USAID support enables WHO to implement key activities such as global monitoring and surveillance, public-private mix, Directly Observed Treatment, Short Course (DOTS) Plus for Multidrug-Resistant (MDR) TB, Green Light Committee for MDR TB, lab strengthening, and technical assistance to support TB-HIV/AIDS activities.